Protagonist Therapeutics Inc buy BMO Capital Markets
Start price
17.08.26
/
50%
€133.00
Target price
17.08.27
€153.72
Performance (%)
0.00%
Price
19.08.26
€133.00
Summary
This prediction is currently active. BMO_Capital_Markets's BUY prediction for Protagonist Therapeutics Inc is currently unchanged. This prediction currently runs until 17.08.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Protagonist Therapeutics Inc | 0.00% |
| iShares Core DAX® | -1.059% |
| iShares Nasdaq 100 | -2.387% |
| iShares Nikkei 225® | -4.361% |
| iShares S&P 500 | -1.778% |
Comments by BMO_Capital_Markets for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) had its price target raised by BMO Capital Markets from $112.00 to $178.00. They now have an "outperform" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€75.50
13.10.25
13.10.25
-
13.10.26
13.10.26
76.16%
19.08.26
19.08.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
11.03.25
11.03.25
€66.33
11.03.26
11.03.26
66.34%
12.03.26
12.03.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
06.12.24
06.12.24
€58.44
06.12.25
06.12.25
62.38%
07.12.25
07.12.25